Envestnet Asset Management’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-8,321
Closed -$343K 3118
2015
Q2
$343K Sell
8,321
-39,115
-82% -$1.4M ﹤0.01% 1887
2015
Q1
$1.67M Buy
47,436
+47,129
+15,351% +$1.59M 0.01% 1058
2014
Q4
$10K Sell
307
-14,417
-98% -$417K ﹤0.01% 1983
2014
Q3
$413K Sell
14,724
-11,952
-45% -$364K ﹤0.01% 836
2014
Q2
$806K Sell
26,676
-266
-1% -$7.34K 0.01% 624
2014
Q1
$746K Sell
26,942
-295
-1% -$7.72K 0.01% 548
2013
Q4
$696K Sell
27,237
-1,381
-5% -$42.6K 0.01% 545
2013
Q3
$855K Buy
28,618
+12,736
+80% +$354K 0.01% 460
2013
Q2
$457K Buy
+15,882
New +$438K 0.01% 607

Other funds holding BRLI

Envestnet Asset Management's BRLI Position: Q3 2015 in Review

Envestnet Asset Management sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 8,321 shares — an estimated $343K sold.

Envestnet Asset Management first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $1.67M in Q1 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • Envestnet Asset Management reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • Envestnet Asset Management sold 8,321 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $343K.
  • Envestnet Asset Management first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
  • Envestnet Asset Management's BIO-REFERENCE LABS INC-NEW- position peaked at $1.67M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Envestnet Asset Management's 13F filing for Q3 2015, filed 13 Nov 2015.